A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Stuart Spencer, Brian Dougherty, Maria Orr, Darren Hodgson, J Carl Barrett, Ursula Matulonis. Lancet Oncol 2014
Times Cited: 835




List of shared articles



Times cited

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Melanie Care, Jeanna McCuaig, Blaise Clarke, Sylvie Grenier, Raymond H Kim, Marjan Rouzbahman, Natalie Stickle, Marcus Bernardini, Tracy L Stockley. Mol Oncol 2021
3

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
Gonzalo Giornelli, Dolores Gallardo, Roberto Hegg, Gonzalo Gomez Abuin, Maximo De La Vega, Maria Lim-Law, Valeria Caceres, Lina Trujillo, Maria Del Pilar Estevez-Diz, Cristian Pacheco,[...]. Future Oncol 2021
0

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
Karolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, Lars Jansen, Linea Osmers, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Matthias Dürst, Norman Häfner, Ingo B Runnebaum. Clin Epigenetics 2021
1

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Jeffrey A How, Amir A Jazaeri, Bryan Fellman, Molly S Daniels, Suzanna Penn, Cara Solimeno, Ying Yuan, Kathleen Schmeler, Jerry S Lanchbury, Kirsten Timms,[...]. Cancers (Basel) 2021
2

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Gang Ji, Qianlan Yao, Longlong Bao, Jing Zhang, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Rui Bi, Xiaoyan Zhou. Ann Transl Med 2021
0

Precision medicine for hereditary tumors in gynecologic malignancies.
Masayuki Sekine, Takayuki Enomoto. J Obstet Gynaecol Res 2021
0


Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.
Christine Bekos, Christoph Grimm, Marlene Kranawetter, Stephan Polterauer, Felicitas Oberndorfer, Yen Tan, Leonhard Müllauer, Christian F Singer. J Pers Med 2021
0

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng,[...]. NAR Cancer 2021
0

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.
Klara Lhotova, Lenka Stolarova, Petra Zemankova, Michal Vocka, Marketa Janatova, Marianna Borecka, Marta Cerna, Sandra Jelinkova, Jan Kral, Zuzana Volkova,[...]. Cancers (Basel) 2020
4

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1


The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer.
Ludivine Dion, Isis Carton, Sylvie Jaillard, Krystel Nyangoh Timoh, Sébastien Henno, Hugo Sardain, Fabrice Foucher, Jean Levêque, Thibault de la Motte Rouge, Susie Brousse,[...]. J Clin Med 2020
3